Deadline: June 2, 2026
Valsartan, Losartan & Irbesartan Contaminated Medication Settlements -- File a Claim by June 2, 2026
By eosguide team · Last updated April 20, 2026
Three class action settlements cover consumers who paid for contaminated Valsartan, Losartan, or Irbesartan blood pressure drugs. Deadline: June 2, 2026. These were blood pressure medications. The carcinogen was not on the label.
Deadline: June 2, 2026
File Your Claim →
Applies to
Nationwide
Main deadline
June 2, 2026
Benefit
Cash payment based on documented purchases of contaminated Valsartan, Losartan, or Irbesartan -- up to $120 for Hetero Valsartan consumers; amounts for other settlements pending court-approved allocation.
Official site
https://sartanmedicationsettlement.com/
What happened
Class period: * Hetero Valsartan: May 1, 2018 through July 31, 2018 * Aurobindo Irbesartan: January 1, 2016 through the present * Vivimed Losartan: Varies by NDC code -- visit sartanmedicationsettlement.com/court-documents/ to confirm your eligibility
- Manufacturers of three widely used blood pressure medications -- Valsartan (Hetero), Irbesartan (Aurobindo), and Losartan (Vivimed) -- are accused of selling products contaminated with nitrosamine impurities classified as probable human carcinogens: NDMA, NDEA, and NMBA, respectively
- The contamination stemmed from the manufacturers' active pharmaceutical ingredient (API) production processes and resulted in large-scale recalls beginning around 2018
- Consumers paid out of pocket for medications they believed were safe and effective; these settlements seek to compensate them for those economic losses
- The cases were consolidated into a federal Multi-District Litigation (MDL) in the U.S. District Court for the District of New Jersey, Case No. 1:19-MD-02875-RBK-SAK
- Three separate settlement agreements have been reached -- one per manufacturer and drug combination -- with a shared claims portal, administrator, and deadline
- All defendants deny wrongdoing and deny that the nitrosamine levels present were carcinogenic
What you can get
Cash payment
Up to $120
Hetero Valsartan only; up to $40 per 30-day supply, max $120 unless higher amount is documented via pharmacy records Cash payment
Key dates
| Action | Date | What it means |
|---|---|---|
| Claim deadline | June 2, 2026 | Last day to file a claim |
| Opt out | June 2, 2026 | Keep your right to sue separately |
| Object | June 2, 2026 | Tell the court you disagree |
Who may qualify
- You are a U.S. resident (including territories and possessions)
- You paid any amount for retail purchases of one of the covered medications during the applicable class period
- For Hetero Valsartan: purchased between May 1, 2018 and July 31, 2018
- For Aurobindo Irbesartan: purchased between January 1, 2016 and the present
- For Vivimed Losartan: purchased under specific National Drug Codes (NDCs) -- see the official site to confirm your NDC
- You are not excluded (e.g., government entities, pharmacy benefit managers, personal injury plaintiffs, or those who opt out)
How to file
- Go to the official settlement website at sartanmedicationsettlement.com
- Click "Submit a Claim" or go directly to the claim portal at sartanmedicationsettlement.pnclassaction.com
- Complete the Claim Form with your purchase information for each applicable medication
- Attach supporting documentation (pharmacy records, receipts) if available -- this is optional but recommended, and required to claim above-cap amounts for Valsartan
- Submit online or mail with a postmark no later than June 2, 2026
Proof required
- Pharmacy records, receipts, or purchase documentation (if available)
- Proof of purchase may be requested by the administrator after submission to verify your claim
- For Hetero Valsartan: documentation is required to receive more than $40 per 30-day supply or more than $120 total
- No documentation is strictly required to file, but submitting it upfront helps avoid delays
Payment timing
Payments will be distributed after the court grants final approval at the hearing scheduled for June 30, 2026. Timing and payment method have not been specified -- check sartanmedicationsettlement.com for updates after the hearing.
Important links
Contact
Phone: 1-866-875-9644
Email: info@sartanMedicationSettlement.com
Mail: info@sartanMedicationSettlement.com
Extra details
- These are three separate legal settlements under one MDL, but they share one claims portal and one deadline -- you only need to go to one website to file for all medications you purchased
- You may qualify for more than one settlement if you purchased more than one of the covered medications
- The Vivimed Losartan settlement is limited to eight specific NDC codes; your prescription bottle or pharmacy records will show the NDC -- check sartanmedicationsettlement.com/court-documents/ to confirm yours
- Do not contact the Court or the Clerk's Office with questions; use the administrator's phone, email, or mail only
- Watch for scams: the only authorized claims website is sartanmedicationsettlement.com
FAQ
What medications are covered by these settlements?
Three blood pressure medications are covered under three separate but related settlements: Valsartan (Hetero brand, May--July 2018), Irbesartan (Aurobindo brand, January 2016 to present), and Losartan (Vivimed brand, specific NDC codes). All three share the same claims portal, administrator, and deadline.
Why were these medications recalled?
The manufacturing processes at each company introduced nitrosamine compounds -- NDMA in Valsartan, NDEA in Irbesartan, and NMBA in Losartan -- into the finished medications. These compounds are classified as probable human carcinogens by regulators. The defendants deny wrongdoing but agreed to pay settlements to resolve the economic loss claims.
How much money could I receive?
For the Hetero Valsartan settlement, consumers may receive up to $40 per 30-day supply purchased, with a maximum of $120 total -- unless pharmacy records document that you paid more. The Aurobindo Irbesartan and Vivimed Losartan amounts per consumer are pending a court-approved allocation plan; check the official site for updates.
What if I took valsartan but it wasn't the Hetero brand?
These settlements cover only Hetero Process III Valsartan (sold May--July 2018), Aurobindo IC ROS Irbesartan, and Vivimed Losartan under the specific NDC codes listed on the official site. Other manufacturers' versions of these medications are not covered here -- though the broader MDL litigation involves additional defendants and settlements that may be announced separately.
Do I need proof of purchase to file?
Not to file, no. But submitting pharmacy records or receipts is strongly encouraged -- it can speed up your claim and, for Hetero Valsartan specifically, is required to receive payment above the $40-per-supply or $120 cap. The administrator may also contact you for documentation after you file.
Can I file for more than one medication?
Yes. If you purchased more than one of the covered medications, you may have claims under more than one settlement. One claim form at the portal should allow you to document purchases for each applicable drug.
What is the deadline to file, opt out, or object?
All three actions -- filing a claim, requesting exclusion, and submitting an objection -- share the same deadline of June 2, 2026. The Final Approval Hearing is scheduled for June 30, 2026.
What happens if I do nothing?
You remain in the class, receive no money, and give up your right to sue any of the settling defendants separately over these economic loss claims. Submitting a Claim Form is the only way to receive a payment.
Use the official website
Always confirm details on the official site. If something feels off, stop and verify before sharing personal info.
Info only. Verify details on the official site. Not legal, financial, or tax advice. Legal
Related guides
Up to $90 cash
Deadline: May 05, 2026
Sutter Health Tracking Pixel Settlement 2026
Sutter Health is paying $21.5 million to settle a class action lawsuit alleging it placed the Meta pixel and Google Anal…
Up to $5,100
Deadline: Jun 01, 2026
Essen Medical Associates data breach settlement
In March 2023, an unauthorized visitor spent nine days exploring Essen Medical Associates' computer systems — and your p…
Avg. MSRP (1 product) or full refund up to 3 products
Deadline: Jul 06, 2026
Tom's of Maine toothpaste settlement -- refund with no receipt required
Turns out "natural" is easier to put on a label than it is to defend in federal court. A $2.9 million settlement covers …
Share this: